Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial

作者：Vicky Makker, Drew Warren Rasco, Nicholas J. Vogelzang, Marcia S. Brose, Allen Lee Cohn, James Walter Mier, Christopher Di Simone, David Michael Hyman, Daniel E. Stepan, Corina E. Dutcus, Emmett V. Schmidt, Matthew D. Guo, Pallavi Sachdev, Robert Shumaker, Carol A Aghajanian, Matthew Hiram Taylor · 发表于：The Lancet Oncology · 年份：2019 · DOI：10.1016/s1470-2045(19)30020-8 · 被引用次数：482 · 研究领域：Endometrial and Cervical Cancer Treatments、Cancer Immunotherapy and Biomarkers、PARP inhibition in cancer therapy